BIONDVAX PHARMACEUTICALS LTD's ticker is BVXV and the CUSIP is 09073Q105. A total of 20 filers reported holding BIONDVAX PHARMACEUTICALS LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $34,000 | -46.9% | 47,000 | -15.3% | 0.01% | -44.4% |
| Q2 2022 | $64,000 | -19.0% | 55,500 | +12.1% | 0.01% | -18.2% |
| Q1 2022 | $79,000 | -26.9% | 49,500 | +7.6% | 0.01% | -26.7% |
| Q4 2021 | $108,000 | +83.1% | 46,000 | +70.4% | 0.02% | +66.7% |
| Q3 2021 | $59,000 | +37.2% | 27,000 | +80.0% | 0.01% | +50.0% |
| Q2 2021 | $43,000 | -6.5% | 15,000 | +25.0% | 0.01% | -14.3% |
| Q1 2021 | $46,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 322,413 | $12,603,000 | 6.64% |
| MORGAN JESS S & CO INC | 74,464 | $2,911,000 | 2.90% |
| Mutual Advisors, LLC | 7,151 | $280,000 | 0.02% |
| BANK HAPOALIM BM | 6,510 | $254,000 | 0.01% |
| NEXT Financial Group, Inc | 1,350 | $53,000 | 0.01% |
| ARK Investment Management | 19,856 | $776,000 | 0.01% |
| HighTower Advisors, LLC | 17,900 | $701,000 | 0.00% |
| Edge Wealth Management LLC | 250 | $10,000 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 1,190 | $47,000 | 0.00% |
| ROYAL BANK OF CANADA | 3,607 | $141,000 | 0.00% |